ESR1 and breast carcinoma: To validate these findings, we repeated these experiments in a second ER+ breast cancer cell line, T47D (Figure 1D), and analyzed stem cell numbers by ALDEFLUOR staining, an alternative marker of BCSCs (Ginestier et al., 2007).